North West England MRC Fellowships in Clinical Pharmacology and Therapeutics
In plain English
AI plain-English summaryBritain’s supply of doctors trained to develop and test new drugs is running thin, and this scheme aims to train 12 clinical fellows over four years to plug the gap. Clinical Pharmacology—the science of how medicines work in people—was flagged by the government’s Office for Life Sciences as vital for both the NHS and the UK’s pharmaceutical industry. Yet the specialty struggles to attract enough trainees. The programme, run jointly by the Universities of Liverpool and Manchester, tackles that shortage head-on. It builds on the existing MRC Centre for Drug Safety Science and partners with AstraZeneca, GlaxoSmithKline, and two contract research organisations. Fellows will spend time in industry labs as well as academic settings, gaining hands-on experience in drug development, safety testing, and regulation. A particular focus is paediatrics, where children often receive medicines tested only in adults. If successful, the scheme will strengthen the UK’s clinical pharmacology workforce—benefiting healthcare, academic research, drug regulation, and ultimately the training of future doctors. It does not aim to discover a new drug or cure, but to ensure the country has the skilled people needed to do that work in the first place.
View original technical description
View the original record at the funder ↗
Researchers
Related Research
Grants with similar aims, by meaning.
Original classification
FellowshipPlain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research. Is something wrong? Let us know